Interface Biosciences
PrivateLast Round
Seed
Dec 5, 2023
Total Funding Raised
$3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Interface Biosciences is a biotechnology company that operates an AI-enabled, metabolomics-based drug discovery platform to develop therapies for inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Interface Biosciences Comparables
Compare Interface Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Enterome | 78% | |
| Kanvas Biosciences | 76% | |
| Siolta Therapeutics | 74% |
Interface Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 5, 2023 |
Key People
Founding team and executive leadership
Interface Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pacific 8 Ventures | Seed |
| Gaingels | Seed |
| Boom Capital | Seed |
| Pear VC | Seed |
| LongeVC | Seed |
| Ulu Ventures | Seed |
| SeedFolio | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 507% MoM, reaching 2.5K.
- Jul 20, 2026
Open roles increased from 0 to 2, representing 100% of headcount.
Interface Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Interface Biosciences's valuation, stock price, and market status.
Is Interface Biosciences a public or private company?
Interface Biosciences is a private company.
What is the current stock price of Interface Biosciences?
Interface Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Interface Biosciences worth (valuation)?
Valuation information for Interface Biosciences is not publicly available.
Can I buy Interface Biosciences stock?
Interface Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Interface Biosciences's last funding round?
Funding round information for Interface Biosciences is not publicly available.
Who are the main investors in Interface Biosciences?
Investor information for Interface Biosciences is not publicly disclosed.
Will Interface Biosciences IPO soon?
No public IPO plans have been announced for Interface Biosciences.
How can I track Interface Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Interface Biosciences's secondary market activity and sign up for updates.